Globus Medical (GMED) Tops Q4 EPS by 9c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $142.6 million versus the consensus estimate of $141.2 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Emkay Global Starts Vedanta Aluminium Metal (VAML:IN) at Buy (1)
• Atmos Energy (ATO) PT Lowered to $185 at Argus